Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Acquires Qualia Clinical Services Assets | Contract Pharma

What are you searching for?

Sign in
Breaking News

ICON Acquires Qualia Clinical Services Assets

ICON has acquired a 33,000-sq.-ft. Phase I facility in Omaha, NE from the former Qualia Clinical Services, Inc., with a capacity of as many as 100 beds.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON has acquired a 33,000-sq.-ft. Phase I facility in Omaha, NE from the former Qualia Clinical Services, Inc., with a capacity of as many as 100 beds.

“This latest acquisition supports our strategy of expanding our Phase I capabilities in the U.S. and brings our total bed capacity there to approximately 225 beds,” commented Dr. Thomas Frey, president, ICON Development Solutions. “We have acquired an excellent facility and we have put in place an experienced team that will ensure the delivery of quality clinical pharmacology services to clients.”

The company has appointed Dr. Gary Curtis as senior vice president, Global Clinical Pharmacology. Dr. Curtis will integrate the Omaha facility with ICON’s existing Phase I units. ICON has also hired key clinical operational staff from Qualia to support the integration.

Dr. Curtis joins the company after spending almost 20 years with MDS Pharma Services where he was responsible for operational execution, strategic growth and integration of MDS’ global early phase business units. Dr. Curtis’ expertise in early phase clinical operations on a global scale will complement ICON’s existing scientific clinical pharmacology leadership, according to a company statement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters